{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:02:32Z","timestamp":1748059352837,"version":"3.41.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"DOI":"10.7759\/cureus.84657","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:54:26Z","timestamp":1747986866000},"source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Study on the Incidence, Mortality, and Risk Factors of Hodgkin Lymphoma in Pakistan"],"prefix":"10.7759","author":[{"given":"Seema","family":"Shafiq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahzadi Noor","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"Khattak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seherish Khan","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Rehan","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-022-01281-9","article-title":"Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis","volume":"15","author":"Huang J","year":"2022","unstructured":"Huang J, Pang WS, Lok V, et al.. Incidence, mortality, risk factors, and trends for Hodgkin lymphoma: a global data analysis. J Hematol Oncol. 2022, 15:57. 10.1186\/s13045-022-01281-9","journal-title":"J Hematol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2009.09.006","article-title":"Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects","volume":"20","author":"Punnett A","year":"2010","unstructured":"Punnett A, Tsang RW, Hodgson DC. Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects. Semin Radiat Oncol. 2010, 20:30-44. 10.1016\/j.semradonc.2009.09.006","journal-title":"Semin Radiat Oncol"},{"key":"ref4","article-title":"Massive adult adenoviral adenoiditis mimicking lymphoma","volume":"7","author":"Bouteille S","year":"2023","unstructured":"Bouteille S, Backaert W, Janssen K, Wollants E, Verbeek S, Laureyns G, Steensels D. Massive adult adenoviral adenoiditis mimicking lymphoma. Int J Clin Virol. 2023, 7:011-3.","journal-title":"Int J Clin Virol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25138","article-title":"Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes","volume":"116","author":"Iyengar P","year":"2010","unstructured":"Iyengar P, Mazloom A, Shihadeh F, Berjawi G, Dabaja B. Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes. Cancer. 2010, 116:3825-9. 10.1002\/cncr.25138","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s1040-8428(00)00046-9","article-title":"Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications","volume":"34","author":"Hsu JL","year":"2000","unstructured":"Hsu JL, Glaser SL. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit Rev Oncol Hematol. 2000, 34:27-53. 10.1016\/s1040-8428(00)00046-9","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS","volume":"108","author":"Biggar RJ","year":"2006","unstructured":"Biggar RJ, Jaffe ES, Goedert JJ, Chaturvedi A, Pfeiffer R, Engels EA. Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS. Blood. 2006, 108:3786-91. 10.1182\/blood-2006-05-024109","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj361","article-title":"Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia","volume":"98","author":"Landgren O","year":"2006","unstructured":"Landgren O, Engels EA, Pfeiffer RM, et al.. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst. 2006, 98:1321-30. 10.1093\/jnci\/djj361","journal-title":"J Natl Cancer Inst"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-021-01446-w","article-title":"Long-term residential exposure to air pollution and Hodgkin lymphoma risk among adults in Denmark: a population-based case-control study","volume":"32","author":"Taj T","year":"2021","unstructured":"Taj T, Poulsen AH, Ketzel M, et al.. Long-term residential exposure to air pollution and Hodgkin lymphoma risk among adults in Denmark: a population-based case-control study. Cancer Causes Control. 2021, 32:935-42. 10.1007\/s10552-021-01446-w","journal-title":"Cancer Causes Control"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/oso\/9780190676827.003.0026","article-title":"Hodgkin lymphoma","author":"Hjalgrim H","year":"2018","unstructured":"Hjalgrim H, Melbye M, Lagiou P. Hodgkin lymphoma. Textbook of Cancer Epidemiology, 3rd Edition. Hans-Olov Adami et al. (ed): Oxford University Press, Oxford, UK; 2018. 627-48. 10.1093\/oso\/9780190676827.003.0026"},{"key":"ref11","unstructured":"International Agency for Research on Cancer. Data visualization tools for exploring the global cancer burden in 2022. (2022). https.\/\/gco.iarc.fr\/today\/home."},{"key":"ref12","unstructured":"United Nations. Human development indices and indicators. 2018 statistical update. (2018). https:\/\/hdr.undp.org\/content\/statistical-update-2018."},{"key":"ref13","unstructured":"World Health Organization. Global Health Observatory data repository. (2022). https.\/\/apps.who.int\/gho\/data\/node.main."},{"key":"ref14","article-title":"Cancer Incidence in Five Continents, Volume XI","author":"Bray F","year":"2021","unstructured":"Bray F, Colombet M, Mery L, Pi\u00f1eros M, Znaor A, Zanetti R, Ferlay J. Cancer Incidence in Five Continents, Volume XI. International Agency for Research on Cancer, Lyon, France; 2021."},{"key":"ref15","unstructured":"World Health Organization. Global health estimates. life expectancy and leading causes of death and disability. (2020). https:\/\/www.who.int\/healthinfo\/mortality_data\/en\/."},{"key":"ref16","unstructured":"NORDCAN. cancer incidence, mortality, prevalence and survival in the Nordic Countries. (2024). https:\/\/www.iarc.who.int\/research-project-websites\/nordcan-cancer-incidence-mortality-prevalence-and-survival-in-the-...."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN - a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"Engholm G","year":"2010","unstructured":"Engholm G, Ferlay J, Christensen N, et al.. NORDCAN - a Nordic tool for cancer information, planning, quality control and research. Acta Oncol. 2010, 49:725-36. 10.3109\/02841861003782017","journal-title":"Acta Oncol"},{"key":"ref18","unstructured":"NIH. Surveillance, Epidemiology, and End Results (SEER) Program. (2020). https.\/\/seer.cancer.gov\/about\/."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim HJ","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000, 19:335-51. 10.1002\/(sici)1097-0258(20000215)19:3&lt;335::aid-sim336&gt;3.0.co;2-z","journal-title":"Stat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0799-1","article-title":"Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study","volume":"12","author":"Zhou L","year":"2019","unstructured":"Zhou L, Deng Y, Li N, et al.. Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study. J Hematol Oncol. 2019, 12:107. 10.1186\/s13045-019-0799-1","journal-title":"J Hematol Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/364975-a-retrospective-study-on-the-incidence-mortality-and-risk-factors-of-hodgkin-lymphoma-in-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:54:32Z","timestamp":1747986872000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/364975-a-retrospective-study-on-the-incidence-mortality-and-risk-factors-of-hodgkin-lymphoma-in-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.84657","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,23]]}}}